Phase II Trial of LBH589 in Refractory Colorectal Cancer
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effects of the study drug, LBH589, on patients
with metastatic colorectal cancer that has continued to grow despite previous treatment.